AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $326,000 | -63.5% | 9,021 | -37.9% | 0.44% | -47.3% |
| Q3 2018 | $894,000 | -25.0% | 14,517 | -17.8% | 0.84% | -23.4% |
| Q2 2018 | $1,192,000 | +19.9% | 17,650 | -3.7% | 1.09% | +4.9% |
| Q1 2018 | $994,000 | +33.4% | 18,321 | +47.0% | 1.04% | +36.9% |
| Q4 2017 | $745,000 | +5.2% | 12,466 | -14.5% | 0.76% | -12.2% |
| Q3 2017 | $708,000 | +57.3% | 14,577 | +70.3% | 0.87% | +27.3% |
| Q2 2017 | $450,000 | – | 8,558 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |